European Journal of Medicinal Chemistry p. 357 - 372 (2019)
Update date:2022-08-03
Topics:
Liu, Hong-Min
Suo, Feng-Zhi
Li, Xiao-Bo
You, Ying-Hua
Lv, Chun-Tao
Zheng, Chen-Xing
Zhang, Guo-Chen
Liu, Yue-Jiao
Kang, Wen-Ting
Zheng, Yi-Chao
Xu, Hai-Wei
Lysine-specific demethylase 1 (LSD1), demethylase against mono- and di - methylated histone3 lysine 4, has emerged as a promising target in oncology. More specifically, it has been demonstrated as a key promoter in acute myeloid leukemia (AML), and several LSD1 inhibitors have already entered into clinical trials for the treatment of AML. In this paper, a series of new indole derivatives were designed and synthesized based on a lead compound obtained by a high-throughput screening with our in-house compound library. Among the synthetic compounds, 9e was characterized as a potent LSD1 inhibitor with an IC50 of 1.230 μM and can inhibit the proliferation of THP-1 cells effectively. And most importantly, this is the first irreversible LSD1 inhibitor that is not derived from monoamine oxidase inhibitors. Hence, the discovery of 9e may serve as a proof of concept work for AML treatment.
View MoreShantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Xiamen Hisunny Chemical Co.,Ltd
website:http://www.hisunnychem.com
Contact:+86-592-3327115
Address:Unit 603,No.879,Xiahe Road,Meixin Building,Xiamen,China
Global United Biotechnology Inc.
Contact:+86-21-61618568
Address:Room 309, Building 6, NO.135, Jinyu Road, Pudong
ZHANGJIAGANG FREE TRADE ZONE YONG HAN INTERNATIONAL TRADING CO., LTD(expird)
Contact:86 512 57910558
Address:qianjin M road
SHIFANG SUHONG CHEMICAL CO.,LTD
Contact:+86-838-2224563
Address:Room 1207 Zongchen Sunshine No.128 Taishan South Road,Deyang City,Sichuan China
Doi:10.1016/0040-4039(95)01243-B
(1995)Doi:10.1002/ps.2780450306
(1995)Doi:10.1016/j.saa.2003.07.003
(2004)Doi:10.1021/ja00405a011
(1981)Doi:10.1016/j.tetlet.2007.05.083
(2007)Doi:10.1016/j.tetlet.2006.02.033
(2006)